Hong Kong
2 Vaccines Approved for Use in Hong Kong
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Approval Source: reuters.com
Inactivated
5 in Clinical Trials in Hong Kong
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
37 trials in 9 countries
DNA
The University of Hong Kong
SARS-CoV-2 DNA Vaccine
Replicating Viral Vector
The University of Hong Kong